12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

  • TransMedics Group TMDX stock moved upwards by 16.4% to $75.1 during Thursday's pre-market session. The market value of their outstanding shares is at $2.3 billion. The company's, Q4 earnings came out yesterday.
  • Adamis Pharmaceuticals ADMP stock rose 15.23% to $0.32. The market value of their outstanding shares is at $47.9 million.
  • Jounce Therapeutics JNCE stock moved upwards by 15.1% to $1.14. The company's market cap stands at $58.9 million.
  • Celyad Oncology CYAD stock moved upwards by 14.91% to $1.31. The market value of their outstanding shares is at $29.5 million.
  • Calliditas Therapeutics CALT shares moved upwards by 13.72% to $20.47. The market value of their outstanding shares is at $609.8 million. As per the press release, Q4 earnings came out today.
  • Lantheus Holdings LNTH stock rose 12.44% to $65.5. The market value of their outstanding shares is at $4.5 billion. As per the press release, Q4 earnings came out today.

Losers

  • Lucira Health LHDX stock fell 38.0% to $0.14 during Thursday's pre-market session. The company's market cap stands at $5.7 million.
  • Infinity Pharmaceuticals INFI stock declined by 29.1% to $0.39. The market value of their outstanding shares is at $34.8 million.
  • Aprea Therapeutics APRE stock declined by 14.43% to $5.4. The company's market cap stands at $14.3 million.
  • Assertio Holdings ASRT shares fell 8.41% to $4.9. The company's market cap stands at $236.6 million.
  • Immix Biopharma IMMX shares decreased by 8.19% to $2.13. The market value of their outstanding shares is at $29.6 million.
  • Processa Pharma PCSA shares declined by 8.13% to $0.66. The company's market cap stands at $16.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!